aspirin has been researched along with Carcinoma, Lobular in 3 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Carcinoma, Lobular: A type of BREAST CANCER where the abnormal malignant cells form in the lobules, or milk-producing glands, of the breast.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Studies suggest regular aspirin use decreases breast cancer (BRCA) risk, with high doses exerting an "anti-cancer" effect." | 7.91 | Aspirin Treatment Effect and Association with PIK3CA Mutation in Breast Cancer: A Biomarker Analysis. ( Jordan, CD; Maihle, N; Simmons, J; Sonbol, MB; Tang, SC; Zhou, Y, 2019) |
| "Aspirin and NSAIDs inhibit COX-2." | 5.37 | COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin. ( Chen, WY; Colditz, GA; Collins, L; Hankinson, SE; Holmes, MD; Schnitt, SJ; Tamimi, RM, 2011) |
| "Studies suggest regular aspirin use decreases breast cancer (BRCA) risk, with high doses exerting an "anti-cancer" effect." | 3.91 | Aspirin Treatment Effect and Association with PIK3CA Mutation in Breast Cancer: A Biomarker Analysis. ( Jordan, CD; Maihle, N; Simmons, J; Sonbol, MB; Tang, SC; Zhou, Y, 2019) |
| "Aspirin and NSAIDs inhibit COX-2." | 1.37 | COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin. ( Chen, WY; Colditz, GA; Collins, L; Hankinson, SE; Holmes, MD; Schnitt, SJ; Tamimi, RM, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, Y | 1 |
| Simmons, J | 1 |
| Jordan, CD | 1 |
| Sonbol, MB | 1 |
| Maihle, N | 1 |
| Tang, SC | 1 |
| Bourdeanu, L | 1 |
| Luu, T | 1 |
| Holmes, MD | 1 |
| Chen, WY | 1 |
| Schnitt, SJ | 1 |
| Collins, L | 1 |
| Colditz, GA | 1 |
| Hankinson, SE | 1 |
| Tamimi, RM | 1 |
1 review available for aspirin and Carcinoma, Lobular
| Article | Year |
|---|---|
Arterial thrombosis associated with adjuvant chemotherapy for breast cancer: a case report.
Topics: Anticoagulants; Antineoplastic Agents; Aspirin; Breast Neoplasms; Carcinoma, Lobular; Chemotherapy, | 2010 |
2 other studies available for aspirin and Carcinoma, Lobular
| Article | Year |
|---|---|
Aspirin Treatment Effect and Association with PIK3CA Mutation in Breast Cancer: A Biomarker Analysis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers, Tumor; Breast Neoplasms; Carcino | 2019 |
COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin.
Topics: Adult; Antineoplastic Agents; Aspirin; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breas | 2011 |